CIK 0001082554
- Large accelerated filer
UNITED THERAPEUTICS Corp
Sign in to watch- Ticker
- UTHR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 521984749
- Phone
- +1 301-608-9292
- Business address
- 1000 SPRING ST, SILVER SPRING, MD, 20910
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $344,206,005
- in 74 filings, $343.4M under 10b5-1 plans
Net −$344,206,005. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-11-24 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −1,560 | $475.11 | $741K | 16,262 |
| 2025-11-24 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −1,621 | $476.09 | $772K | 14,641 |
| 2025-11-24 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −2,989 | $477.22 | $1.4M | 11,652 |
| 2025-11-24 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −1,630 | $478.14 | $779K | 10,022 |
| 2025-11-24 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −315 | $478.73 | $151K | 9,707 |
| 2025-11-24 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −640 | $480.71 | $308K | 9,067 |
| 2025-11-24 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −794 | $481.55 | $382K | 8,273 |
| 2025-11-24 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −131 | $482.29 | $63K | 8,142 |
| 2025-11-24 | EDGEMOND JAMES CFO AND TREASURER | Exercise or conversion · Stock Option 10b5-1 | −21,000 | 517 | ||
| 2025-11-24 | ROTHBLATT MARTINE A Chairperson & CEO | Exercise or conversion 10b5-1 | +4,000 | $120.26 | $481K | 4,130 |
| 2025-11-24 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −2,500 | $469.73 | $1.2M | 1,630 |
| 2025-11-24 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,500 | $472.53 | $709K | 130 |
| 2025-11-24 | ROTHBLATT MARTINE A Chairperson & CEO | Exercise or conversion · Stock Option 10b5-1 | −4,000 | 70,000 | ||
| 2025-11-21 | ROTHBLATT MARTINE A Chairperson & CEO | Exercise or conversion 10b5-1 | +4,000 | $120.26 | $481K | 4,130 |
| 2025-11-21 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,500 | $473.31 | $710K | 2,630 |
| 2025-11-21 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −2,450 | $475.42 | $1.2M | 180 |
| 2025-11-21 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −50 | $476.07 | $24K | 130 |
| 2025-11-21 | ROTHBLATT MARTINE A Chairperson & CEO | Exercise or conversion · Stock Option 10b5-1 | −4,000 | 74,000 | ||
| 2025-11-20 | ROTHBLATT MARTINE A Chairperson & CEO | Exercise or conversion 10b5-1 | +4,000 | $120.26 | $481K | 4,130 |
| 2025-11-20 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,000 | $476.80 | $477K | 3,130 |
Page 179 of 214 · 4,273 trades